Binders Excipients

Binders Excipients Market Outlook

The global binders excipients market is projected to reach approximately USD 5.10 billion by 2035, growing at a compound annual growth rate (CAGR) of around 5.8% from 2025 to 2035. The increasing demand for pharmaceuticals and the growing trend of complex formulations in drug manufacturing are key growth factors driving this market. Moreover, the expanding biopharmaceutical sector, innovation in excipient formulations, and rising consumer preference for effective dosage forms significantly contribute to market expansion. Additionally, the demographic shift towards an aging population is expected to escalate the need for medication, further boosting the demand for binders excipients. The continuous advancements in technology and the introduction of novel excipients are also anticipated to create lucrative opportunities for manufacturers in this sector.

Growth Factor of the Market

One of the primary growth factors of the binders excipients market is the rising prevalence of chronic diseases, which necessitates innovative and effective therapeutic options. Pharmaceutical companies are increasingly focusing on developing novel drug delivery systems that require advanced excipients to enhance the bioavailability and efficacy of the formulations. In addition, the growth of the generics market has significantly impacted the demand for binders, as generic drugs often rely on efficiency and cost-effectiveness, of which binders are a crucial component. The expansion of the nutraceutical and food industries, which utilize binders in various formulations, further propels market growth. Furthermore, the regulatory environment is becoming more favorable, with agencies increasingly approving new excipients, enabling manufacturers to explore new market segments. The trend towards personalized medicine, emphasizing customized formulations, also enhances the demand for sophisticated binder excipients.

Key Highlights of the Market

• The binders excipients market is expected to witness significant growth, driven by increasing pharmaceutical demand.
• Starch and cellulose are the leading product types in the binders excipients segment.
• North America is the dominant region, accounting for a substantial market share due to advanced healthcare infrastructure.
• There is a rising trend in online distribution channels, enhancing market accessibility for pharmaceutical products.
• Technological advancements in excipient formulations are anticipated to create new opportunities for market players.

By Product Type

Starch:

Starch plays a pivotal role as a binder excipient due to its excellent adhesive properties and versatility in pharmaceutical formulations. It is derived from various plant sources, making it a natural choice for many formulations. Starch provides unique functionality as it can enhance the mechanical properties of tablets and capsules, improving their stability and bioavailability. As the market for starch continues to expand, it is primarily driven by its use in solid dosage forms and its ability to act as a disintegrating agent in some formulations. Furthermore, innovations in modified starches are expected to enhance their applications, thereby solidifying starch’s position as a key binder excipient in the market.

Cellulose:

Cellulose is another critical binder excipient that is widely used in the pharmaceutical industry due to its robust binding capabilities and excellent flow properties. Cellulose derivatives, such as microcrystalline cellulose and hydroxypropyl methylcellulose (HPMC), are commonly employed in various dosage forms, including tablets and capsules. The demand for cellulose is largely driven by its ability to improve the tablet's hardness and disintegration, ensuring efficient drug release. Additionally, cellulose is a non-toxic and biodegradable polymer, making it an environmentally friendly option. As the pharmaceutical industry shifts toward green chemistry, cellulose is expected to gain more traction as a preferred binder excipient.

Povidone:

Povidone, also known as polyvinylpyrrolidone (PVP), is a synthetic polymer widely utilized as a binder excipient due to its superior solubility and film-forming properties. It is particularly favored in the formulation of tablets and capsules, where it acts as a binder and stabilizer. The ability of povidone to enhance drug solubility makes it a popular choice for poorly soluble active pharmaceutical ingredients (APIs). Furthermore, the demand for povidone is being propelled by its applications in the formulation of various drug delivery systems, including oral and topical formulations. As the industry continues to evolve, the development of new grades of povidone is anticipated to expand its application in the pharmaceutical market.

Copovidone:

Copovidone, a copolymer of povidone, is increasingly recognized for its binding properties, especially in the formulation of solid dosage forms. This excipient is particularly advantageous for drugs that require improved flow characteristics and enhanced tablet hardness. Copovidone is often used in combination with other excipients to create optimized formulations that meet specific release profiles. The growth in the market for copovidone is also attributed to its application in the production of film coatings for tablets, which protect the drug from environmental factors while ensuring patient compliance. As the demand for high-performance excipients rises, copovidone is poised for significant growth in the binders excipients market.

HPMC:

Hydroxypropyl methylcellulose (HPMC) is a cellulose derivative that has gained widespread acceptance in the pharmaceutical industry due to its multifunctional properties as a binder, thickener, and film-forming agent. HPMC is particularly valued for its ability to provide controlled release of active ingredients in formulations. This property makes it ideal for extended-release tablets and capsules, addressing the growing consumer preference for sustained-release medication. Furthermore, HPMC is also utilized in various applications beyond pharmaceuticals, including food and cosmetics, which enhances its market potential. The increasing emphasis on developing innovative drug delivery systems will likely propel the demand for HPMC in the binders excipients market.

By Application

Tablets:

The tablet segment holds a significant share in the binders excipients market, primarily due to the widespread use of tablets as a preferred dosage form in the pharmaceutical industry. Binders play a critical role in ensuring that tablets maintain their structural integrity and provide effective drug release. The rising prevalence of chronic diseases and the growing elderly population necessitate the development of more effective tablet formulations, further driving the demand for binder excipients. Additionally, the increasing preference for over-the-counter medications in tablet form enhances the growth potential of this segment, as pharmaceutical companies continue to innovate and improve tablet formulations.

Capsules:

Capsules represent another vital application in the binders excipients market, favored for their ease of swallowing and ability to mask the taste of bitter drugs. The versatility of capsules allows for the incorporation of various drug types, including powders, pellets, and liquids. Binders are essential in ensuring the stability and performance of capsules, contributing to their effectiveness. The rising demand for dietary supplements and nutraceuticals in capsule form has significantly impacted the market, as manufacturers seek to enhance the quality and performance of their formulations. As the trend toward personalized medicine grows, the capsule segment is expected to witness substantial growth in the coming years.

Softgels:

Softgels are increasingly becoming a popular dosage form due to their ability to encapsulate liquid ingredients, providing a unique delivery system for pharmaceuticals and nutraceuticals. The use of binders in softgel formulations is crucial for ensuring the integrity and stability of the gelatin shell. As the market for softgels expands, driven by the rising demand for liquid dietary supplements and the need for innovative drug delivery systems, the role of binders is expected to gain importance. The growth of the global softgel market reflects the increasing consumer preference for easy-to-swallow formulations, which is likely to further boost the demand for binder excipients.

Powders:

The powders application segment is gaining traction in the binders excipients market due to the growing interest in powder-based formulations for various therapeutic areas. Binders are essential in enhancing the flow and compressibility of powders, ensuring that they can be effectively processed into tablets or capsules. The emphasis on developing inhalable and injectable powder formulations, especially in the context of the increasing prevalence of respiratory diseases and the need for effective vaccine delivery systems, is expected to drive the growth of this segment. Additionally, the formulation of powders for instant drinks and nutraceuticals is also contributing to the expanding market for binders excipients.

Pellets:

Pellets are emerging as a preferred dosage form due to their unique properties, including controlled release capabilities and reduced side effects. The demand for pellet formulations is rising, especially in the context of chronic disease management, where precise dosing is crucial. Binders play a vital role in the formulation of pellets, ensuring their structural integrity and enhancing drug release profiles. As pharmaceutical companies continue to focus on developing innovative dosage forms, the use of binders in pellet formulations is anticipated to grow. Furthermore, the increasing exploration of advanced drug delivery systems is expected to generate significant opportunities for binder excipients in the pellets segment.

By Distribution Channel

Pharmacies:

Pharmacies remain one of the primary distribution channels for binder excipients, as they play a crucial role in providing access to various pharmaceutical products. The demand for over-the-counter medications, dietary supplements, and prescription drugs, all of which utilize binder excipients, drives the growth of this channel. Moreover, the increasing number of retail pharmacies, particularly in urban areas, enhances market accessibility for consumers. The trend toward personalized medicine also contributes to the expansion of pharmacies as a distribution channel, as patients increasingly seek tailored formulations that require high-quality binder excipients.

Hospitals:

The hospital distribution channel is significant in the binders excipients market, particularly in terms of bulk purchasing and the formulation of specialized medications. Hospitals often require large quantities of pharmaceuticals, many of which rely on binder excipients for their effectiveness. The increasing emphasis on the development of injectable and intravenous medications, which often utilize binders for stability and efficacy, further drives demand in this segment. Additionally, the rise in hospital admissions due to chronic diseases and surgical procedures is expected to propel the need for binders in hospitals, reflecting the importance of this channel in the overall market.

Online Stores:

The rise of e-commerce has significantly transformed the distribution landscape for binders excipients, with online stores emerging as a popular channel for consumers. The convenience of online shopping and the increasing preference for home delivery of pharmaceutical products are key factors driving this trend. Online platforms provide access to a wide range of products, including specialized formulations that may not be available in physical stores. Furthermore, the COVID-19 pandemic accelerated the adoption of online shopping, leading to sustained growth in this channel. As consumer behavior continues to evolve, online stores are expected to play an increasingly vital role in the distribution of binder excipients.

Drug Stores:

Drug stores represent another crucial distribution channel for the binders excipients market, providing consumers with access to a wide range of pharmaceutical products. These establishments typically offer a variety of medications, including those in tablet and capsule forms that rely on binders for performance. The growth of drug stores, particularly in suburban and rural areas, enhances the accessibility of binders excipients to a broader consumer base. Moreover, the increasing prevalence of self-medication and the growing interest in health and wellness products contribute to the demand for binders in drug stores, solidifying their role in the market.

Others:

The "Others" distribution channel category encompasses various alternative outlets, including health food stores, specialty shops, and direct sales from manufacturers. These channels cater to niche markets, such as dietary supplements and nutraceuticals, which often utilize binder excipients. As consumer preferences shift toward natural and organic products, the significance of alternative distribution channels is on the rise. Furthermore, the trend towards health-conscious living and the increasing demand for specialty formulations are anticipated to propel growth in this segment. Overall, the diversification of distribution channels reflects the dynamic nature of the binders excipients market and enhances consumer access to a wider range of products.

By Ingredient Type

Microcrystalline Cellulose:

Microcrystalline cellulose (MCC) is a widely used excipient in the pharmaceutical industry, known for its excellent binding and disintegration properties. It is derived from cellulose and is characterized by its fine particle size and high surface area. MCC is extensively employed in tablet formulations, as it enhances the mechanical strength of tablets while ensuring optimal disintegration and drug release. The growing demand for high-quality excipients in the pharmaceutical sector is driving the adoption of MCC, as it meets the stringent quality and regulatory requirements. Additionally, the increasing trend towards natural and plant-based ingredients further bolsters the market for microcrystalline cellulose.

Lactose:

Lactose is one of the most commonly used excipients in the pharmaceutical industry, particularly in tablet and capsule formulations. It serves as a filler and binder, providing structure and stability to formulations. The demand for lactose is primarily driven by its compatibility with a wide range of active pharmaceutical ingredients, making it a preferred choice for many manufacturers. Additionally, the increasing prevalence of lactose-free products, driven by dietary restrictions and preferences, is expected to expand the market for lactose derivatives. The versatility of lactose as an excipient in various formulations, including powders and granules, further enhances its market potential.

Croscarmellose Sodium:

Croscarmellose sodium is widely recognized for its exceptional disintegrating properties in pharmaceutical formulations. As a super disintegrant, it enhances the release of active ingredients from tablets and capsules, improving the overall effectiveness of the product. The growing demand for rapid-release formulations, especially in the context of chronic disease management, drives the adoption of croscarmellose sodium in the binders excipients market. Furthermore, its compatibility with various active ingredients and its ability to enhance patient compliance make it a valuable excipient in the pharmaceutical industry. As innovation continues, the demand for croscarmellose sodium is expected to rise significantly in the coming years.

Sodium Starch Glycolate:

Sodium starch glycolate is a widely used excipient known for its excellent binding and disintegrating capabilities. It plays a crucial role in the formulation of tablets and capsules, enhancing the bioavailability and efficacy of pharmaceutical products. The growth of the sodium starch glycolate market is primarily driven by the increasing demand for effective drug delivery systems, as it facilitates rapid disintegration and dissolution of solid dosage forms. Additionally, the rising trend towards generic formulations, which often utilize sodium starch glycolate for cost-effective production, further propels market growth. The versatility of sodium starch glycolate in various formulations underscores its importance in the binders excipients market.

Pregelatinized Starch:

Pregelatinized starch has gained prominence in the binders excipients market due to its unique properties that enhance the performance of pharmaceutical formulations. This modified starch is used as a binder and disintegrant, providing improved flowability and tablet hardness. The increasing demand for high-quality excipients that facilitate the formulation of complex drug delivery systems is driving the growth of pregelatinized starch in the pharmaceutical sector. Furthermore, the expanding interest in natural and plant-based excipients enhances the market potential for pregelatinized starch, as it meets the consumer preference for safe and effective formulations. As the industry continues to innovate, pregelatinized starch will likely play an increasingly significant role in the binders excipients market.

By Region

The North American region currently dominates the binders excipients market, accounting for approximately 40% of the global market share in 2025. This strong position is attributed to the presence of a well-established pharmaceutical industry, advanced research and development capabilities, and a robust regulatory framework. The region is home to numerous leading pharmaceutical companies that are actively engaged in the development of innovative drug formulations, driving the demand for high-quality binder excipients. Moreover, the increasing prevalence of chronic diseases and the growing elderly population further contribute to the rising demand for pharmaceutical products in North America. The region is expected to witness a CAGR of 5.5% during the forecast period, reflecting its sustained growth trajectory.

Europe holds the second position in the binders excipients market, making up around 30% of the global share as of 2025. The demand in this region is driven by the increasing focus on research and development in the pharmaceutical sector, as well as the rising demand for biologics and biosimilars. Countries such as Germany, France, and the United Kingdom are leading contributors to the market, bolstered by their strong healthcare infrastructure and investment in healthcare innovation. The growing trend towards personalized medicine and the need for tailored drug formulations further enhance the demand for binder excipients in Europe. As the market continues to evolve, Europe is expected to experience a steady growth rate in the coming years.

Opportunities

The binders excipients market presents numerous opportunities for growth, particularly in the context of technological advancements and innovations in excipient formulations. As pharmaceutical companies increasingly focus on developing complex drug delivery systems, there is a growing need for high-performance binders that can enhance the bioavailability and efficacy of active pharmaceutical ingredients. This demand creates opportunities for research and development in the field of excipient technology, leading to the introduction of novel binder formulations that cater to specific therapeutic needs. Manufacturers that invest in R&D to develop innovative solutions are likely to gain a competitive advantage in the market and capture a larger market share.

Furthermore, the rising trend towards sustainability and eco-friendly formulations is expected to create significant opportunities in the binders excipients market. As consumers become more conscious of environmental issues, the demand for natural and plant-based excipients is on the rise. Pharmaceutical manufacturers that prioritize sustainability and incorporate eco-friendly binders into their formulations will not only meet consumer preferences but also align with regulatory requirements aimed at reducing environmental impact. This shift towards sustainable practices is anticipated to drive innovation and foster collaborations between excipient manufacturers and pharmaceutical companies, creating a win-win situation for all stakeholders involved.

Threats

Despite the growth potential of the binders excipients market, several threats may challenge its expansion. One significant threat is the increasing competition from low-cost alternative excipients, particularly from emerging markets. Manufacturers in these regions may offer cheaper options that can impact the pricing and profitability of established excipient suppliers. Furthermore, the continuous pressure from regulatory agencies for stringent quality standards adds an additional layer of complexity, as companies must invest significantly in compliance and quality assurance processes. Failure to meet these evolving regulatory requirements could lead to product recalls or penalties, impacting the overall reputation and market share of manufacturers in the binders excipients market.

Another critical concern is the potential disruption of supply chains, exacerbated by global events such as pandemics or geopolitical tensions. The reliance on a limited number of suppliers for raw materials may lead to vulnerabilities in the production process, ultimately affecting the availability of binder excipients in the market. Additionally, fluctuations in prices of raw materials can impact production costs, making it challenging for manufacturers to maintain competitive pricing. Addressing these threats requires a proactive approach, including diversifying supply chains, investing in alternative sourcing strategies, and fostering strong relationships with suppliers.

Competitor Outlook

• Ashland Global Holdings Inc.
• Dow Chemical Company
• Evonik Industries AG
• JRS Pharma GmbH & Co. KG
• FMC Corporation
• Merck KGaA
• Roquette Frères
• DuPont de Nemours, Inc.
• Pharmaceutics International, Inc.
• Colorcon, Inc.
• Avantor, Inc.
• Ingredion Incorporated
• Gattefossé S.A.
• Wacker Chemie AG
• Sinopharm Group Co., Ltd.

The competitive landscape of the binders excipients market is characterized by the presence of several key players, each striving to enhance their market position through innovation, product differentiation, and strategic collaborations. Major companies are focusing on research and development to introduce advanced excipient formulations that cater to the evolving needs of the pharmaceutical industry. Furthermore, mergers and acquisitions are common strategies employed by market players to expand their product portfolios and strengthen their presence in emerging markets. The competitive dynamics in this sector are fueled by the ongoing trend towards sustainable and eco-friendly practices, prompting companies to invest in eco-friendly excipients that align with consumer preferences.

Ashland Global Holdings Inc. is one of the leading players in the binders excipients market, recognized for its extensive portfolio of high-performance excipients that cater to various pharmaceutical applications. The company's commitment to innovation and sustainability has positioned it as a preferred partner for pharmaceutical manufacturers seeking advanced excipient solutions. Similarly, Evonik Industries AG leverages its expertise in polymer chemistry to develop cutting-edge excipients that enhance drug formulations. The company's strategic focus on research and sustainable practices aligns with the growing demand for environmentally friendly excipients, further solidifying its market position.

Another prominent player is Roquette Frères, known for its wide range of natural and synthetic excipients that serve diverse pharmaceutical applications. The company's emphasis on quality and regulatory compliance has earned it a strong reputation in the market. Additionally, Colorcon, Inc. is recognized for its innovative solutions in the excipients market, providing a comprehensive range of binder excipients that enhance the performance of pharmaceutical formulations. As the industry evolves, these key players are expected to play a significant role in shaping the future of the binders excipients market, leveraging their expertise and capabilities to meet the growing demands of the pharmaceutical sector.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Merck KGaA
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Avantor, Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Colorcon, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 FMC Corporation
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Wacker Chemie AG
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Dow Chemical Company
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Evonik Industries AG
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Gattefossé S.A.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Ingredion Incorporated
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Roquette Frères
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 DuPont de Nemours, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 JRS Pharma GmbH & Co. KG
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Sinopharm Group Co., Ltd.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Ashland Global Holdings Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Pharmaceutics International, Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Binders Excipients Market, By Application
    • 6.1.1 Tablets
    • 6.1.2 Capsules
    • 6.1.3 Softgels
    • 6.1.4 Powders
    • 6.1.5 Pellets
  • 6.2 Binders Excipients Market, By Product Type
    • 6.2.1 Starch
    • 6.2.2 Cellulose
    • 6.2.3 Povidone
    • 6.2.4 Copovidone
    • 6.2.5 HPMC
  • 6.3 Binders Excipients Market, By Ingredient Type
    • 6.3.1 Microcrystalline Cellulose
    • 6.3.2 Lactose
    • 6.3.3 Croscarmellose Sodium
    • 6.3.4 Sodium Starch Glycolate
    • 6.3.5 Pregelatinized Starch
  • 6.4 Binders Excipients Market, By Distribution Channel
    • 6.4.1 Pharmacies
    • 6.4.2 Hospitals
    • 6.4.3 Online Stores
    • 6.4.4 Drug Stores
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Binders Excipients Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Binders Excipients market is categorized based on

By Product Type

• Starch
• Cellulose
• Povidone
• Copovidone
• HPMC

By Application

• Tablets
• Capsules
• Softgels
• Powders
• Pellets

By Distribution Channel

• Pharmacies
• Hospitals
• Online Stores
• Drug Stores
• Others

By Ingredient Type

• Microcrystalline Cellulose
• Lactose
• Croscarmellose Sodium
• Sodium Starch Glycolate
• Pregelatinized Starch

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Ashland Global Holdings Inc.
• Dow Chemical Company
• Evonik Industries AG
• JRS Pharma GmbH & Co. KG
• FMC Corporation
• Merck KGaA
• Roquette Frères
• DuPont de Nemours, Inc.
• Pharmaceutics International, Inc.
• Colorcon, Inc.
• Avantor, Inc.
• Ingredion Incorporated
• Gattefossé S.A.
• Wacker Chemie AG
• Sinopharm Group Co., Ltd.